A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis

Clinical trial NCT02492321 · COMPLETED

Trial details

NCT number: NCT02492321
Sponsor: Eleven Biotherapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Conjunctivitis (AC)

Start date: 2015-07-01
Primary completion: 2015-11-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.